SELLAS Life Sciences Group, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
CEO Angelos M. Stergiou and CFO John T. Burns certified the June 30, 2026 Form 10-Q on August 11, 2026 pursuant to Sarbanes-Oxley Sections 302 and 906. Both officers affirmed financial statements fairly present the company's condition and operations, and that disclosure controls and internal controls over financial reporting are effective with no material weaknesses or fraud disclosed. No specific business transactions, financial metrics, or material changes are detailed in these certification exhibits.
Why this rating
Boilerplate SOX certifications are mandatory routine filing compliance. No business events, transactions, or material changes disclosed. Administrative procedural filing only.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.